Searched for
FEBUXOSTAT TABLETS
India Inc warms up to the idea of product recalls as pharma, auto industries lead the chargeIn FY23, 30 companies undertook voluntary product recalls, while 16 were forced to recall their products, shows data sourced from Prime Dat...
Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violationSun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing p...
Stocks in news: RIL, Paytm, HUL, IndusInd Bank, HDFC BankPrivate lender IndusInd Bank's standalone net profit grew 17% to Rs 2,298 crore for the quarter ended December. Net interest income for the...
Zydus gets US FDA final nod for Febuxostat tablets for treating high uric acidAccording to the statement from Zydus, Febuxostat tablets are indicated to lower hyperuricemia (high uric acid in the blood) in patients wi...
Dr Reddy's launches generic drug in the US marketThe company has launched the product, which is a generic version of Teijin Ltd's Uloric tablets, after getting approval from the US Food an...
After Market: Yes Bank, Icra crack; 124 stocks raring to riseAfter lacklustre trade for most part of the day, the market built up gains in afternoon session.
Alembic Pharma gets USFDA nod for Febuxostat tabletsShares of Alembic Pharmaceuticals were trading 3.86 per cent higher at Rs 523 apiece.
Zydus Cadila gets USFDA nod for 2 drugsThe group has more than 241 approvals, and so far filed over 340 abbreviated new drug applications (ANDAs) since it started filings in 2003...
Alembic Pharma gets tentative nod from USFDA for FebuxostatThe product is therapeutic equivalent to the reference listed drug Uloric tablets, 40 mg, 80 mg of Takeda Pharmaceuticals USA Inc, it added.